GlobeNewswire01.25.19
Globus Medical Inc., a musculoskeletal solutions company, recently announced that the SECURE-C Cervical Artificial Disc is now covered by Anthem, one of the largest health benefits companies in the United States with close to 40 million medical members and over 73 million lives covered.
Approved by the FDA in 2012, SECURE-C is designed for reconstruction and motion preservation at the operated disc level, unlike traditional motion-eliminating fusion surgery. A long term, seven-year clinical trial follow-up study published in the prominent International Journal of Spine Surgery demonstrated the superiority of SECURE-C in terms of overall success, compared to Anterior Cervical Discectomy and Fusion (ACDF), the current standard of care for cervical disc disease.
At seven-year post-operative follow-up, patients treated with SECURE-C exhibited the following results compared to patients treated with ACDF:
“The long term clinical results validate that SECURE-C creates a significant improvement in patients’ lives over the long term, an important factor in expanding payer coverage,” said Globus Medical’s president, Anthony Williams. “With the addition of Anthem, SECURE-C is now covered by all major third-party payers in every state and strengthens our position for growth in the cervical artificial disc market.”
Approved by the FDA in 2012, SECURE-C is designed for reconstruction and motion preservation at the operated disc level, unlike traditional motion-eliminating fusion surgery. A long term, seven-year clinical trial follow-up study published in the prominent International Journal of Spine Surgery demonstrated the superiority of SECURE-C in terms of overall success, compared to Anterior Cervical Discectomy and Fusion (ACDF), the current standard of care for cervical disc disease.
At seven-year post-operative follow-up, patients treated with SECURE-C exhibited the following results compared to patients treated with ACDF:
- Statistically superior composite protocol-specified overall success results (86.3 percent vs. 70.0 percent)
- Statistically superior composite FDA-defined overall success results (79.2 percent vs. 63.6 percent)
- Greater percentage of patients with at least 25 percent improvement in Neck Disability Index, a measure of pain and function (90.4 percent vs. 86.0 percent)
- Lower rate of subsequent surgery at the original treated level (4.2 percent vs. 15.3 percent)
- Lower rate of adjacent level surgery (4.2 percent vs. 16.0 percent)
“The long term clinical results validate that SECURE-C creates a significant improvement in patients’ lives over the long term, an important factor in expanding payer coverage,” said Globus Medical’s president, Anthony Williams. “With the addition of Anthem, SECURE-C is now covered by all major third-party payers in every state and strengthens our position for growth in the cervical artificial disc market.”
